share_log

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Benzinga ·  May 21 08:06

Gainers

  • Biodexa Pharmaceuticals (NASDAQ:BDRX) shares increased by 67.7% to $2.13 during Tuesday's pre-market session. The market value of their outstanding shares is at $9.3 million.
  • Durect (NASDAQ:DRRX) stock rose 23.07% to $1.28. The market value of their outstanding shares is at $39.7 million.
  • Larimar Therapeutics (NASDAQ:LRMR) stock rose 17.33% to $8.53. The market value of their outstanding shares is at $544.2 million.
  • Tevogen Bio Holdings (NASDAQ:TVGN) shares moved upwards by 16.64% to $0.91. The market value of their outstanding shares is at $149.7 million.
  • Envoy Medical (NASDAQ:COCH) shares rose 14.81% to $3.72. The company's market cap stands at $72.9 million. As per the news, the Q1 earnings report came out 4 days ago.
  • Citius Pharma (NASDAQ:CTXR) shares increased by 14.62% to $0.76. The market value of their outstanding shares is at $136.6 million.

Losers

  • Scorpius Holdings (AMEX:SCPX) stock decreased by 21.9% to $0.12 during Tuesday's pre-market session. The market value of their outstanding shares is at $8.2 million.
  • Orgenesis (NASDAQ:ORGS) stock decreased by 16.31% to $0.46. The company's market cap stands at $15.8 million.
  • SINTX Techs (NASDAQ:SINT) stock decreased by 15.68% to $0.1. The company's market cap stands at $11.6 million.
  • Kazia Therapeutics (NASDAQ:KZIA) stock fell 15.28% to $0.23. The market value of their outstanding shares is at $6.1 million.
  • NovaBay Pharmaceuticals (AMEX:NBY) shares decreased by 13.77% to $0.15. The company's market cap stands at $5.6 million.
  • Akanda (NASDAQ:AKAN) stock declined by 12.12% to $0.12. The company's market cap stands at $4.0 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment